Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study.

Wang, Jinkui; Li, Mujie; Guo, Peng; He, Dawei

Wang, Jinkui; Li, Mujie; Guo, Peng; He, Dawei.

Affiliation

Wang J; Department of Urology, Children's Hospital of Chongqing Medical University, 2 ZhongShan Rd, Chongqing, 400013, China.
Li M; Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Techn
Guo P; Department of Urology, Children's Hospital of Chongqing Medical University, 2 ZhongShan Rd, Chongqing, 400013, China.
He D; Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Techn

J Orthop Surg Res ; 18(1): 465, 2023 Jun 27.

Article de En | MEDLINE | ID: mdl-37370182

Sujet(s)
Mots clés

Challenge; Chemotherapy; Osteosarcoma; SEER; Survival

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs osseuses / Ostéosarcome Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: J Orthop Surg Res Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google